Shares of UnitedHealth Group Incorporated (NYSE:UNH) recorded -1.82% loss during trading session on February 11th, 2019. The script traded as low as $256.34 and last traded at $257.14. 4.77 million shares changed exchanged hands during trading, a drop of -18.19% from the 30-day average session volume of 4.04M shares. The firm had previously closed at $261.90. The company has $988.11M outstanding shares, a price-to-earnings ratio of 21.10, price-to-earnings-growth ratio of 1.12and a beta of 0.85. The company has a RSI of 41.59, ATR of 5.04 and a volatility of 2.11% this week. UNH has a 52 week low price of $212.01 and a 52 week high price of $287.94.
Investors have identified the tech company UnitedHealth Group Incorporated as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around 254.08B, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
UnitedHealth Group Incorporated (UNH) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For UNH, the company has in raw cash 10.26 billion on their books with 2.39 billion currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on a decline. In terms of their assets, the company currently has 0 total, with 10 million as their total liabilities. This figure have given the company a good sense of viability under numerous contexts.
UNH were able to record 11.81 billion as free cash flow during the recently reported quarter of the year, this saw their quarterly net cash flow reduce by 1.72 billion. In cash movements, the company had a total of 13.32 billion as operating cash flow.
Potential earnings growth for UnitedHealth Group Incorporated (UNH)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the third quarter of the year, UnitedHealth Group Incorporated recorded a total of 56.56 billion in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 0.11% coming in sequential stages and their sales for the third quarter increasing by 0.01%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 42.88 billion trying to sell their products during the last quarter, with the result yielding a gross income of 13.68 billion. This allows shareholders to hold on to 988.11M with the revenue now reading 3410 cents per share. This is a figure that is close to analyst’s prediction for their fourth quarter (3.48 cents a share).
Is the stock of UNH attractive?
Having a look at the company’s valuation, the company is expected to record 16.60 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on UNH sounds very interesting.
In related news, Director BURKE RICHARD T sold 11,500 shares of the company’s stock in a transaction that recorded on January 23rd, 2019. The sale was performed at an average price of 268.00, for a total value of 3,082,000. As the sale deal closes, the Director BURKE RICHARD T now sold 5,000 shares of the company’s stock, valued at 1,333,035. Also, Director BURKE RICHARD T sold 15,000 shares of the company’s stock in a deal that was recorded on January 17th, 2019. The shares were sold at an average price of 260.55 per share, with a total market value of 193,872. Following this completion of acquisition, the Director now holds 6,090 shares of the company’s stock, valued at 1,715,686. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.40%.
11 out of 25 analysts covering the stock have rated it a Buy, while 1 have maintained a Hold recommendation on UnitedHealth Group Incorporated stock. 0 analysts has assigned a Sell rating on the UNH stock. The 12-month mean consensus price target for the company’s shares has been set at $305.96.